hotspot -WSS

hotspot

author：comprehensive 2025-09-06 02:14:07 - browse：6156

SAN FRANCISCO — The small hotel meeting room was packed like a rush hour subway. Bankers in dark suits were crammed tightly into a small room on the third floor of the Westin St. Francis, lining the aisles and doorways, and spilling out into the hallways where it was impossible to hear.

The occasion: Nvidia, the chipmaker whose market capitalization has soared beyond $1 trillion because of its role in the revolutionary work occurring in artificial intelligence, was presenting at the J.P. Morgan Healthcare Conference, and describing why it thinks AI, running on Nvidia computers, could dramatically increase the number of new medicines that are created while reducing their cost, ushering in an age of “digital biology.”

When Kimberly Powell, Nvidia’s vice president of health care, finished her presentation, the room erupted in applause.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Gene therapy’s promise and the high cost of hope

WSS

How Brent Saunders' Allergan experiment failed

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Live blog: Hearing on CRISPR

Medicare proceeds with plan to claw back hospital funds

Why the advice to take all your antibiotics may be wrong

How neuroscience research could help beat back brain cancer

focus

hotspot

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Medicare must police algorithms in Medicare Advantage, Dems say

Medical records are filled with copy

How to convince healthy people to buy insurance

Alkermes shareholders re

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Bright Health sells Medicare Advantage business to Molina

Readout LOUD podcast: ESMO highlights & Roivant's big deal

ChatGPT in medicine: STAT answers readers' burning questions

Live blog: Hearing on CRISPR

leisure time

Gene therapy’s promise and the high cost of hope

After Sarepta trial failure, Duchenne families brace for more debate

Humans aren't the only ones with an imagination. Rats have it too

How neuroscience research could help beat back brain cancer

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Kidney transplant patients stopped immunosuppressants in trial

entertainment

leisure time

entertainment

explore